Diligence memo · auto-generated · as of July 2, 2026
Ovagene Oncology, Inc.
Ovagene Oncology, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Ovagene Oncology, Inc. operates in Other Health Care, based in IRVINE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Ovagene Oncology, Inc. has raised $2.1M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.6M on 2011-06-18.
Most recent recorded round closed around 2011-06-18.
Valuation (modeled)modeled
Provath models Ovagene Oncology, Inc. at approximately $40M (range $1.4M–$312M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.99× the median modeled value of Seed Other Health Care companies in 2010–2012 (243 peers) — value vs value, same stage and era. Within the normal band (99% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 15.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 3.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 48% of Other Health Care peers (5377 compared).
Modeled value ranks above 64% of those peers.
Closest niche peers: Coolsystems Inc, Device Innovation Group, LLC, Envoy Partners Llc, Kare Partners LLC, CuMed LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.